Digging Into Past HBOC Clinical Trials
- PMID: 35446268
- DOI: 10.1097/MJT.0000000000001512
Digging Into Past HBOC Clinical Trials
Conflict of interest statement
The author has no conflicts of interest to declare.
References
-
- Mackenzie C, Dube GP, Pitman A, et al. Users guide to pitfalls and lessons learned about HBOC-201 during clinical traials, expanded access, and clinical use in 1,701 patients. Shock. 2019;52:92–99.
-
- Zumberg M, Gorlin J, Griffiths EA, et al. A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusionm is not an option. Transfusion. 2020;60:932–939.
-
- Sen Gupta A. Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules. Shock. 2019;52:70–83.
-
- Pusateri AE, Glassberg E, Weiskopf RB. Reassessment of the need for an oxygen carrier for the treatment of traumatic hemorrhage when blood is not an option. Shock. 2019;52:55–59.
-
- NRAC. Requirements for Delivery of, “Artificial Blood” to the Military. Washington, DC; 1992. U.S.Army Surgeon General.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous